The small molecule Bcl-2/Mcl-1 inhibitor TW-37 shows single-agent cytotoxicity in neuroblastoma cell lines View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2019-12

AUTHORS

Stefanie Klenke, Neval Akdeli, Patrick Stelmach, Lukas Heukamp, Johannes H. Schulte, Hagen S. Bachmann

ABSTRACT

BACKGROUND: High-risk neuroblastoma with N-Myc amplification remains a therapeutic challenge in paediatric oncology. Antagonism of pro-death Bcl-2 homology (BH) proteins to pro-survival BH members such as Mcl-1 and Bcl-2 has become a treatment approach, but previous studies suggest that a combined inhibition of Bcl-2 and Mcl-1 is necessary. TW-37 inhibits Mcl-1 and Bcl-2 with almost the same affinity. However, single-agent cytotoxicity of TW-37 in neuroblastoma cell lines has not been investigated. METHODS: Cell viability, apoptosis, proliferation and changes in growth properties were determined in SKNAS, IMR-5, SY5Y and Kelly cells after treatment with TW-37. After transfection with Mcl-1 or Bcl-2 siRNA, apoptosis and proliferation were investigated in Kelly cells. Mice with Kelly cell line xenografts were treated with TW-37 and tumor growth, survival and apoptosis were determined. RESULTS: Cell lines with N-Myc amplification were more sensitive to TW-37 treatment, IC50 values for IMR-5 and Kelly cells being 0.28 μM and 0.22 μM, compared to SY5Y cells and SKNAS cells (IC50 0.96 μM and 0.83 μM). Treatment with TW-37 resulted in increased apoptosis and reduced proliferation rates, especially in IMR5 and Kelly cells. Bcl-2 as well as Mcl-1 knockdown induced apoptosis in Kelly cells. TW-37 led to a decrease in tumor growth and a favorable survival (p = 0.0379) in a Kelly neuroblastoma xenografts mouse model. CONCLUSION: TW-37 has strong single-agent cytotoxicity in vitro and in vivo. Therefore, combined inhibition of Bcl-2/Mcl-1 by TW-37 in N-Myc amplified neuroblastoma may represent an interesting therapeutic strategy. More... »

PAGES

243

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12885-019-5439-1

DOI

http://dx.doi.org/10.1186/s12885-019-5439-1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1112851488

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30885150


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Essen University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.410718.b", 
          "name": [
            "Institute of Pharmacogenetics, University Hospital Essen, Essen, Germany", 
            "Department of Anesthesiology and Intensive Care, University Hospital Essen, Essen, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Klenke", 
        "givenName": "Stefanie", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Essen University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.410718.b", 
          "name": [
            "Institute of Pharmacogenetics, University Hospital Essen, Essen, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Akdeli", 
        "givenName": "Neval", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Essen University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.410718.b", 
          "name": [
            "Institute of Pharmacogenetics, University Hospital Essen, Essen, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stelmach", 
        "givenName": "Patrick", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "NEO New Oncology AG, Cologne, Germany", 
            "Institute of Hematopathology Hamburg, Hamburg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Heukamp", 
        "givenName": "Lukas", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Charit\u00e9", 
          "id": "https://www.grid.ac/institutes/grid.6363.0", 
          "name": [
            "Department of Pediatric Oncology and Hematology, Charit\u00e9 Berlin, Berlin, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schulte", 
        "givenName": "Johannes H.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Witten/Herdecke University", 
          "id": "https://www.grid.ac/institutes/grid.412581.b", 
          "name": [
            "Institute of Pharmacogenetics, University Hospital Essen, Essen, Germany", 
            "Institute of Pharmacology and Toxicology, Center for Biomedical Education and Research (ZBAF), School of Medicine, Faculty of Health, Witten/Herdecke University, Stockumer Str 10, 58453, Witten, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bachmann", 
        "givenName": "Hagen S.", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.18632/oncotarget.8547", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000850112"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-11-3603", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007299173"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(07)60983-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010395561"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1101/cshperspect.a014415", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012538217"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/305245a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014246353", 
          "https://doi.org/10.1038/305245a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-11-1939", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014823961"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ccell.2016.01.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015618060"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s13048-015-0130-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016812623", 
          "https://doi.org/10.1186/s13048-015-0130-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s13048-015-0130-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016812623", 
          "https://doi.org/10.1186/s13048-015-0130-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1756-8722-2-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020192103", 
          "https://doi.org/10.1186/1756-8722-2-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.onc.1211017", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024837250", 
          "https://doi.org/10.1038/sj.onc.1211017"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00001622-199511000-00012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025174639"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00001622-199511000-00012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025174639"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1535-7163.mct-08-1078", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026765935"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-08-3060", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031580450"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2010.04.024", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032335158"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.canlet.2006.09.010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034483518"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc2297", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041493658", 
          "https://doi.org/10.1038/nrc2297"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc3526", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044463510", 
          "https://doi.org/10.1038/nrc3526"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-06-1574", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047606072"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.canlet.2005.01.048", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048139294"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.canlet.2005.01.048", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048139294"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/jm060460o", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055950462"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/jm060460o", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055950462"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4161/cbt.8.16.8964", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1072295250"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1999.17.7.2264", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074549838"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/15384101.2017.1329066", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090618229"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/15384101.2017.1329066", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090618229"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pone.0184501", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092338416"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-12", 
    "datePublishedReg": "2019-12-01", 
    "description": "BACKGROUND: High-risk neuroblastoma with N-Myc amplification remains a therapeutic challenge in paediatric oncology. Antagonism of pro-death Bcl-2 homology (BH) proteins to pro-survival BH members such as Mcl-1 and Bcl-2 has become a treatment approach, but previous studies suggest that a combined inhibition of Bcl-2 and Mcl-1 is necessary. TW-37 inhibits Mcl-1 and Bcl-2 with almost the same affinity. However, single-agent cytotoxicity of TW-37 in neuroblastoma cell lines has not been investigated.\nMETHODS: Cell viability, apoptosis, proliferation and changes in growth properties were determined in SKNAS, IMR-5, SY5Y and Kelly cells after treatment with TW-37. After transfection with Mcl-1 or Bcl-2 siRNA, apoptosis and proliferation were investigated in Kelly cells. Mice with Kelly cell line xenografts were treated with TW-37 and tumor growth, survival and apoptosis were determined.\nRESULTS: Cell lines with N-Myc amplification were more sensitive to TW-37 treatment, IC50 values for IMR-5 and Kelly cells being 0.28\u2009\u03bcM and 0.22\u2009\u03bcM, compared to SY5Y cells and SKNAS cells (IC50 0.96\u2009\u03bcM and 0.83\u2009\u03bcM). Treatment with TW-37 resulted in increased apoptosis and reduced proliferation rates, especially in IMR5 and Kelly cells. Bcl-2 as well as Mcl-1 knockdown induced apoptosis in Kelly cells. TW-37 led to a decrease in tumor growth and a favorable survival (p\u00a0=\u20090.0379) in a Kelly neuroblastoma xenografts mouse model.\nCONCLUSION: TW-37 has strong single-agent cytotoxicity in vitro and in vivo. Therefore, combined inhibition of Bcl-2/Mcl-1 by TW-37 in N-Myc amplified neuroblastoma may represent an interesting therapeutic strategy.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s12885-019-5439-1", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1024632", 
        "issn": [
          "1471-2407"
        ], 
        "name": "BMC Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "19"
      }
    ], 
    "name": "The small molecule Bcl-2/Mcl-1 inhibitor TW-37 shows single-agent cytotoxicity in neuroblastoma cell lines", 
    "pagination": "243", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "372372b7999177b945e2433a3b92666b951797d73d8c48e12a4ed980fc26a98c"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30885150"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "100967800"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12885-019-5439-1"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1112851488"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12885-019-5439-1", 
      "https://app.dimensions.ai/details/publication/pub.1112851488"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T13:20", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000368_0000000368/records_78970_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs12885-019-5439-1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12885-019-5439-1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12885-019-5439-1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12885-019-5439-1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12885-019-5439-1'


 

This table displays all metadata directly associated to this object as RDF triples.

186 TRIPLES      21 PREDICATES      53 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12885-019-5439-1 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author N3d220e9d756b46fbb3f4cb083cf81ca6
4 schema:citation sg:pub.10.1038/305245a0
5 sg:pub.10.1038/nrc2297
6 sg:pub.10.1038/nrc3526
7 sg:pub.10.1038/sj.onc.1211017
8 sg:pub.10.1186/1756-8722-2-8
9 sg:pub.10.1186/s13048-015-0130-x
10 https://doi.org/10.1016/j.canlet.2005.01.048
11 https://doi.org/10.1016/j.canlet.2006.09.010
12 https://doi.org/10.1016/j.ccell.2016.01.002
13 https://doi.org/10.1016/j.ijrobp.2010.04.024
14 https://doi.org/10.1016/s0140-6736(07)60983-0
15 https://doi.org/10.1021/jm060460o
16 https://doi.org/10.1080/15384101.2017.1329066
17 https://doi.org/10.1097/00001622-199511000-00012
18 https://doi.org/10.1101/cshperspect.a014415
19 https://doi.org/10.1158/0008-5472.can-08-3060
20 https://doi.org/10.1158/0008-5472.can-11-3603
21 https://doi.org/10.1158/1078-0432.ccr-06-1574
22 https://doi.org/10.1158/1078-0432.ccr-11-1939
23 https://doi.org/10.1158/1535-7163.mct-08-1078
24 https://doi.org/10.1200/jco.1999.17.7.2264
25 https://doi.org/10.1371/journal.pone.0184501
26 https://doi.org/10.18632/oncotarget.8547
27 https://doi.org/10.4161/cbt.8.16.8964
28 schema:datePublished 2019-12
29 schema:datePublishedReg 2019-12-01
30 schema:description BACKGROUND: High-risk neuroblastoma with N-Myc amplification remains a therapeutic challenge in paediatric oncology. Antagonism of pro-death Bcl-2 homology (BH) proteins to pro-survival BH members such as Mcl-1 and Bcl-2 has become a treatment approach, but previous studies suggest that a combined inhibition of Bcl-2 and Mcl-1 is necessary. TW-37 inhibits Mcl-1 and Bcl-2 with almost the same affinity. However, single-agent cytotoxicity of TW-37 in neuroblastoma cell lines has not been investigated. METHODS: Cell viability, apoptosis, proliferation and changes in growth properties were determined in SKNAS, IMR-5, SY5Y and Kelly cells after treatment with TW-37. After transfection with Mcl-1 or Bcl-2 siRNA, apoptosis and proliferation were investigated in Kelly cells. Mice with Kelly cell line xenografts were treated with TW-37 and tumor growth, survival and apoptosis were determined. RESULTS: Cell lines with N-Myc amplification were more sensitive to TW-37 treatment, IC50 values for IMR-5 and Kelly cells being 0.28 μM and 0.22 μM, compared to SY5Y cells and SKNAS cells (IC50 0.96 μM and 0.83 μM). Treatment with TW-37 resulted in increased apoptosis and reduced proliferation rates, especially in IMR5 and Kelly cells. Bcl-2 as well as Mcl-1 knockdown induced apoptosis in Kelly cells. TW-37 led to a decrease in tumor growth and a favorable survival (p = 0.0379) in a Kelly neuroblastoma xenografts mouse model. CONCLUSION: TW-37 has strong single-agent cytotoxicity in vitro and in vivo. Therefore, combined inhibition of Bcl-2/Mcl-1 by TW-37 in N-Myc amplified neuroblastoma may represent an interesting therapeutic strategy.
31 schema:genre research_article
32 schema:inLanguage en
33 schema:isAccessibleForFree true
34 schema:isPartOf N6a1ae788b7e14f8b96e6ad2175103c1b
35 Nafa6c27d1f0f45ddb69c1de605d3c39f
36 sg:journal.1024632
37 schema:name The small molecule Bcl-2/Mcl-1 inhibitor TW-37 shows single-agent cytotoxicity in neuroblastoma cell lines
38 schema:pagination 243
39 schema:productId N24c8a272d4284f5b922f870cc72bafe8
40 N49cdb66fa62a4159b8d3fc22240fd70c
41 Na63b795e3d684b07bd20c166d9b1a6ea
42 Nbf623a19140e4427ac60d8ef2fb16eb0
43 Ncb4b6671061740399beb7d17b98047ff
44 schema:sameAs https://app.dimensions.ai/details/publication/pub.1112851488
45 https://doi.org/10.1186/s12885-019-5439-1
46 schema:sdDatePublished 2019-04-11T13:20
47 schema:sdLicense https://scigraph.springernature.com/explorer/license/
48 schema:sdPublisher N881ca1b65d82410b8be3380b8ddac2ae
49 schema:url https://link.springer.com/10.1186%2Fs12885-019-5439-1
50 sgo:license sg:explorer/license/
51 sgo:sdDataset articles
52 rdf:type schema:ScholarlyArticle
53 N140fb65b7d6842dcb639f9cbbbf397a0 rdf:first N23aa7e289c0c4f3eadd3c57e6c14acec
54 rdf:rest N59c4d0f646b7488fb4ce9864c59df6de
55 N23aa7e289c0c4f3eadd3c57e6c14acec schema:affiliation https://www.grid.ac/institutes/grid.6363.0
56 schema:familyName Schulte
57 schema:givenName Johannes H.
58 rdf:type schema:Person
59 N24c8a272d4284f5b922f870cc72bafe8 schema:name nlm_unique_id
60 schema:value 100967800
61 rdf:type schema:PropertyValue
62 N3314cfd1e4d341f7b0f25a7d29e6ee44 rdf:first N94dba4393ac64012afdcd48ef4cb292f
63 rdf:rest Nc49d780f80a74d01aa3b2ae39f2d8765
64 N39d3087d2ef64ecb95de9ce6c89a60a4 schema:affiliation https://www.grid.ac/institutes/grid.410718.b
65 schema:familyName Klenke
66 schema:givenName Stefanie
67 rdf:type schema:Person
68 N3d220e9d756b46fbb3f4cb083cf81ca6 rdf:first N39d3087d2ef64ecb95de9ce6c89a60a4
69 rdf:rest N3314cfd1e4d341f7b0f25a7d29e6ee44
70 N49cdb66fa62a4159b8d3fc22240fd70c schema:name readcube_id
71 schema:value 372372b7999177b945e2433a3b92666b951797d73d8c48e12a4ed980fc26a98c
72 rdf:type schema:PropertyValue
73 N59c4d0f646b7488fb4ce9864c59df6de rdf:first Nab89193b74354d96945fecef92135650
74 rdf:rest rdf:nil
75 N5b3a39662467480c8b165979e2980b30 rdf:first Nfdf38ef1d16244119aaf4352001bd0ce
76 rdf:rest N140fb65b7d6842dcb639f9cbbbf397a0
77 N6803138d520e46c2aa1bf78812d49de4 schema:name Institute of Hematopathology Hamburg, Hamburg, Germany
78 NEO New Oncology AG, Cologne, Germany
79 rdf:type schema:Organization
80 N6a1ae788b7e14f8b96e6ad2175103c1b schema:volumeNumber 19
81 rdf:type schema:PublicationVolume
82 N881ca1b65d82410b8be3380b8ddac2ae schema:name Springer Nature - SN SciGraph project
83 rdf:type schema:Organization
84 N94dba4393ac64012afdcd48ef4cb292f schema:affiliation https://www.grid.ac/institutes/grid.410718.b
85 schema:familyName Akdeli
86 schema:givenName Neval
87 rdf:type schema:Person
88 Na469a476519b4f95a92bee6cf78538dc schema:affiliation https://www.grid.ac/institutes/grid.410718.b
89 schema:familyName Stelmach
90 schema:givenName Patrick
91 rdf:type schema:Person
92 Na63b795e3d684b07bd20c166d9b1a6ea schema:name dimensions_id
93 schema:value pub.1112851488
94 rdf:type schema:PropertyValue
95 Nab89193b74354d96945fecef92135650 schema:affiliation https://www.grid.ac/institutes/grid.412581.b
96 schema:familyName Bachmann
97 schema:givenName Hagen S.
98 rdf:type schema:Person
99 Nafa6c27d1f0f45ddb69c1de605d3c39f schema:issueNumber 1
100 rdf:type schema:PublicationIssue
101 Nbf623a19140e4427ac60d8ef2fb16eb0 schema:name doi
102 schema:value 10.1186/s12885-019-5439-1
103 rdf:type schema:PropertyValue
104 Nc49d780f80a74d01aa3b2ae39f2d8765 rdf:first Na469a476519b4f95a92bee6cf78538dc
105 rdf:rest N5b3a39662467480c8b165979e2980b30
106 Ncb4b6671061740399beb7d17b98047ff schema:name pubmed_id
107 schema:value 30885150
108 rdf:type schema:PropertyValue
109 Nfdf38ef1d16244119aaf4352001bd0ce schema:affiliation N6803138d520e46c2aa1bf78812d49de4
110 schema:familyName Heukamp
111 schema:givenName Lukas
112 rdf:type schema:Person
113 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
114 schema:name Medical and Health Sciences
115 rdf:type schema:DefinedTerm
116 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
117 schema:name Oncology and Carcinogenesis
118 rdf:type schema:DefinedTerm
119 sg:journal.1024632 schema:issn 1471-2407
120 schema:name BMC Cancer
121 rdf:type schema:Periodical
122 sg:pub.10.1038/305245a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014246353
123 https://doi.org/10.1038/305245a0
124 rdf:type schema:CreativeWork
125 sg:pub.10.1038/nrc2297 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041493658
126 https://doi.org/10.1038/nrc2297
127 rdf:type schema:CreativeWork
128 sg:pub.10.1038/nrc3526 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044463510
129 https://doi.org/10.1038/nrc3526
130 rdf:type schema:CreativeWork
131 sg:pub.10.1038/sj.onc.1211017 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024837250
132 https://doi.org/10.1038/sj.onc.1211017
133 rdf:type schema:CreativeWork
134 sg:pub.10.1186/1756-8722-2-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020192103
135 https://doi.org/10.1186/1756-8722-2-8
136 rdf:type schema:CreativeWork
137 sg:pub.10.1186/s13048-015-0130-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1016812623
138 https://doi.org/10.1186/s13048-015-0130-x
139 rdf:type schema:CreativeWork
140 https://doi.org/10.1016/j.canlet.2005.01.048 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048139294
141 rdf:type schema:CreativeWork
142 https://doi.org/10.1016/j.canlet.2006.09.010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034483518
143 rdf:type schema:CreativeWork
144 https://doi.org/10.1016/j.ccell.2016.01.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015618060
145 rdf:type schema:CreativeWork
146 https://doi.org/10.1016/j.ijrobp.2010.04.024 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032335158
147 rdf:type schema:CreativeWork
148 https://doi.org/10.1016/s0140-6736(07)60983-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010395561
149 rdf:type schema:CreativeWork
150 https://doi.org/10.1021/jm060460o schema:sameAs https://app.dimensions.ai/details/publication/pub.1055950462
151 rdf:type schema:CreativeWork
152 https://doi.org/10.1080/15384101.2017.1329066 schema:sameAs https://app.dimensions.ai/details/publication/pub.1090618229
153 rdf:type schema:CreativeWork
154 https://doi.org/10.1097/00001622-199511000-00012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025174639
155 rdf:type schema:CreativeWork
156 https://doi.org/10.1101/cshperspect.a014415 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012538217
157 rdf:type schema:CreativeWork
158 https://doi.org/10.1158/0008-5472.can-08-3060 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031580450
159 rdf:type schema:CreativeWork
160 https://doi.org/10.1158/0008-5472.can-11-3603 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007299173
161 rdf:type schema:CreativeWork
162 https://doi.org/10.1158/1078-0432.ccr-06-1574 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047606072
163 rdf:type schema:CreativeWork
164 https://doi.org/10.1158/1078-0432.ccr-11-1939 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014823961
165 rdf:type schema:CreativeWork
166 https://doi.org/10.1158/1535-7163.mct-08-1078 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026765935
167 rdf:type schema:CreativeWork
168 https://doi.org/10.1200/jco.1999.17.7.2264 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074549838
169 rdf:type schema:CreativeWork
170 https://doi.org/10.1371/journal.pone.0184501 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092338416
171 rdf:type schema:CreativeWork
172 https://doi.org/10.18632/oncotarget.8547 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000850112
173 rdf:type schema:CreativeWork
174 https://doi.org/10.4161/cbt.8.16.8964 schema:sameAs https://app.dimensions.ai/details/publication/pub.1072295250
175 rdf:type schema:CreativeWork
176 https://www.grid.ac/institutes/grid.410718.b schema:alternateName Essen University Hospital
177 schema:name Department of Anesthesiology and Intensive Care, University Hospital Essen, Essen, Germany
178 Institute of Pharmacogenetics, University Hospital Essen, Essen, Germany
179 rdf:type schema:Organization
180 https://www.grid.ac/institutes/grid.412581.b schema:alternateName Witten/Herdecke University
181 schema:name Institute of Pharmacogenetics, University Hospital Essen, Essen, Germany
182 Institute of Pharmacology and Toxicology, Center for Biomedical Education and Research (ZBAF), School of Medicine, Faculty of Health, Witten/Herdecke University, Stockumer Str 10, 58453, Witten, Germany
183 rdf:type schema:Organization
184 https://www.grid.ac/institutes/grid.6363.0 schema:alternateName Charité
185 schema:name Department of Pediatric Oncology and Hematology, Charité Berlin, Berlin, Germany
186 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...